Back to search
Generated on www.datasnoop.be
Visé Voie, 81, 4000 LiègeNACE 21209 — Vervaardiging van overige farmaceutische producten
Key FinancialsFY2024
Revenue
€13.6M
↓ 3.2%
EBITDA
€720K
↑ 27.1%
Margin
5.3%
Employees
26
↓ 1.5%
Leverage
-0.4x
Net Debt / EBITDA
Equity Ratio
80.5%
Equity / Assets
Int. Coverage
258.8x
EBITDA / Int. Exp
DSO
123d
Days to collect
DPO
7d
Days to pay
Financial History Summary
| Year | Revenue | EBITDA | Margin | Net Profit | FTE |
|---|---|---|---|---|---|
| 2024 | €13.6M -€455K ▼ -3.2% | €720K +€154K ▲ +27.1% | 5.3% | €577K +€124K ▲ +27.4% | 26 -€0 ▼ -1.5% |
| 2023 | €14.1M +€69K ▲ +0.5% | €566K -€1.4M ▼ -71.8% | 4.0% | €453K -€1.0M ▼ -69.3% | 26 -€2 ▼ -7.7% |
| 2022 | €14.0M | €2.0M | 14.4% | €1.5M | 28 |
Key People
No administrator data
Recent Publications
No publications yet
Key Shareholders
No shareholder data
Key Subsidiaries
No subsidiary data